Dexcom (DXCM) Consolidated Net Income (2010 - 2026)

Dexcom (DXCM) has 17 years of Consolidated Net Income data on file, last reported at $199.5 million in Q1 2026.

• On a quarterly basis, Consolidated Net Income rose 89.28% year-over-year to $199.5 million in Q1 2026; TTM through Mar 2026 was $930.4 million, a 73.84% increase from a year earlier, with the FY2025 full-year figure at $836.3 million, up 45.14% from the prior year.
• Consolidated Net Income for Q1 2026 stood at $199.5 million, down from $267.3 million in the prior quarter.
• Over the last five years, Consolidated Net Income for DXCM reached as high as $283.8 million in Q3 2025 and fell as low as $48.6 million in Q1 2023.
• Historically, Consolidated Net Income has averaged $146.7 million across 5 years, with a median of $134.6 million in 2024.
• Across the five-year window, Consolidated Net Income soared 1832.08% in 2022 and plunged 50.05% in 2023, its largest moves.
• Year by year, Consolidated Net Income stood at $91.8 million in 2022, then surged by 179.19% to $256.3 million in 2023, then tumbled by 40.81% to $151.7 million in 2024, then jumped by 76.2% to $267.3 million in 2025, then dropped by 25.36% to $199.5 million in 2026.
• Per Business Quant data, the three most recent Consolidated Net Income figures were $199.5 million in Q1 2026, $267.3 million in Q4 2025, and $283.8 million in Q3 2025.